Apellis Pharmaceuticals, Inc. (APLS) — Dilution Risk Analysis
Current Snapshot
Apellis Pharmaceuticals, Inc. (APLS) has a DilutionWatch score of 25/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 25/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 8, 3 2.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-05-01 | 0001492422-26-000105 |
| 4 | 2026-04-20 | 0001193125-26-163917 |
| 4 | 2026-04-08 | 0001492422-26-000099 |
| 3 | 2026-04-06 | 0000950157-26-000479 |
| 4 | 2026-03-13 | 0001193125-26-106090 |
| 3 | 2026-03-03 | 0001492422-26-000091 |
| 4 | 2026-03-03 | 0001492422-26-000092 |
| 4 | 2026-02-13 | 0001492422-26-000083 |
| 4 | 2026-02-05 | 0001492422-26-000081 |
| 4 | 2026-01-30 | 0001492422-26-000073 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 15 months | Source |
| Three-year share count growth | 8.03% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 25/10) Source
- Cash Runway
- 15 months Source
- Share Count Growth (3-Year)
- 8.03% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.